Rhenman & Partners Asset Management Ab Ionis Pharmaceuticals Inc Transaction History
Rhenman & Partners Asset Management Ab
- $959 Million
- Q4 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 212,500 shares of IONS stock, worth $6.41 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
212,500
Previous 195,000
8.97%
Holding current value
$6.41 Million
Previous $7.81 Million
4.89%
% of portfolio
0.78%
Previous 0.65%
Shares
6 transactions
Others Institutions Holding IONS
# of Institutions
409Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$497 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$427 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$346 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$311 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$237 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.28B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...